|
⚲
|
| Renavance Pharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001468422 |
| Sale | 2009-07-01 ($0.5 M Offered, $0.5 M Sold) |
| Fund | |
| Phone | 4153784099 |
| Address | 330 Deertrail Lane Mill Valley, 94941 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| John Donovan | |
| Mark Kessel | |
| Andrew Busser |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
JAT Select Fund, L.P.
✚
|
0.0 | |
|
JAT Select Fund, Ltd.
✚
|
0.0 | |
|
Javelin II CMR AIVB, LLC
✚
|
0.0 | |
|
Javelin II CMR AIV, L.P.
✚
|
0.0 | |
|
Jawfish Games Inc.
✚
|
0.0 | |
|
Jax Beer Ventures I, LLC
✚
|
0.0 | |
|
Jaynes Michael
✚
|
0.0 | |
|
J.B. Capital Investments, Inc.
✚
|
0.0 | |
|
SI-0905 Fund I, a series of Roll Up Vehicles, LP
✚
|
0.0 | |
|
JA Gaingels Fund III, a series of Zachary Ginsburg Funds, LP
✚
|
0.0 |